datamatters24/research-document-archive huggingface dataset:
110TH CONGRESS 
1ST SESSION 
H. CON. RES. 34
CONCURRENT RESOLUTION
Whereas Percy Julian was born on April 11, 1899, in Mont-
gomery, Alabama, the son of a railway clerk and the first 
member of his family to attend college, graduating from 
DePauw University in 1920, receiving a M.S. degree 
from Harvard University in 1923 and a Ph.D. from the 
University of Vienna in 1931;
•HCON 34 EH 
Whereas in 1935 Dr. Julian became the first to discover a 
process to synthesize physostigmine, the drug used in the 
treatment of glaucoma; 
Whereas Dr. Julian later pioneered a commercial process to 
synthesize cortisone from soy beans and yams, enabling 
the widespread use of cortisone as an affordable treat-
ment of arthritis; 
Whereas Dr. Julian was the first African American chemist 
elected to the National Academy of Sciences in 1973 for 
his lifetime of scientific accomplishments, held over 130 
patents at the time of his death in 1975, and dedicated 
much of his life to the advancement of African Americans 
in the sciences; and 
Whereas Dr. Julian’s life story has been documented in the 
PBS NOVA film ‘‘Forgotten Genius’’: Now, therefore, be 
it
Resolved by the House of Representatives (the Senate 
concurring), That the Congress honors the life of Percy 
Lavon Julian, a pioneer in the field of organic chemistry 
research and development and the first and only African 
American chemist to be inducted into the National Acad-
emy of Sciences. 
Passed the House of Representatives January 31, 
2007. 
Attest:
Clerk.
110TH CONGRESS 
1ST SESSION 
H. CON. RES. 34
CONCURRENT RESOLUTION 
Honoring the life of Percy Lavon Julian, a pioneer 
in the field of organic chemistry research and de-
velopment and the first and only African Amer-
ican chemist to be inducted into the National 
Academy of Sciences.
I 
110TH CONGRESS 
1ST SESSION 
H. R. 514 
To designate the facility of the United States Postal Service located at 
16150 Aviation Loop Drive in Brooksville, Florida, as the ‘‘Sergeant 
Lea Robert Mills Brooksville Aviation Branch Post Office’’. 
IN THE HOUSE OF REPRESENTATIVES 
JANUARY 17, 2007 
Ms. GINNY BROWN-WAITE of Florida (for herself, Ms. CORRINE BROWN of 
Florida, Mr. MEEK of Florida, Ms. ROS-LEHTINEN, Mr. MARIO DIAZ- 
BALART of Florida, Mr. MILLER of Florida, Mr. CRENSHAW, Mr. KEL-
LER of Florida, Mr. MACK, Mr. BUCHANAN, Mr. BOYD of Florida, Mr. 
PUTNAM, Mr. MICA, Mr. STEARNS, Mr. HASTINGS of Florida, Mr. LIN-
COLN DIAZ-BALART of Florida, Mr. YOUNG of Florida, Mr. FEENEY, Ms. 
WASSERMAN SCHULTZ, Mr. KLEIN of Florida, Mr. MAHONEY of Florida, 
Mr. WEXLER, Ms. CASTOR, Mr. WELDON of Florida, and Mr. BILIRAKIS) 
introduced the following bill; which was referred to the Committee on 
Oversight and Government Reform 
A BILL 
To designate the facility of the United States Postal Service 
located at 16150 Aviation Loop Drive in Brooksville, 
Florida, as the ‘‘Sergeant Lea Robert Mills Brooksville 
Aviation Branch Post Office’’. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
VerDate Aug 31 2005 
23:03 Jan 18, 2007
Jkt 059200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H514.IH
H514
frosa on PROD1PC71 with BILLS
H. Con. Res. 34
Agreed to February 1, 2007
One Hundred Tenth Congress
of the
United States of America 
AT THE FIRST SESSION 
Begun and held at the City of Washington on Thursday, 
the fourth day of January, two thousand and seven 
Concurrent Resolution
Whereas Percy Julian was born on April 11, 1899, in Montgomery, 
Alabama, the son of a railway clerk and the first member of 
his family to attend college, graduating from DePauw University 
in 1920, receiving a M.S. degree from Harvard University in 
1923 and a Ph.D. from the University of Vienna in 1931;
Whereas in 1935 Dr. Julian became the first to discover a process 
to synthesize physostigmine, the drug used in the treatment 
of glaucoma;
Whereas Dr. Julian later pioneered a commercial process to syn-
thesize cortisone from soy beans and yams, enabling the wide-
spread use of cortisone as an affordable treatment of arthritis;
Whereas Dr. Julian was the first African American chemist elected 
to the National Academy of Sciences in 1973 for his lifetime 
of scientific accomplishments, held over 130 patents at the time 
of his death in 1975, and dedicated much of his life to the 
advancement of African Americans in the sciences; and
Whereas Dr. Julian’s life story has been documented in the PBS 
NOVA film ‘‘Forgotten Genius’’: Now, therefore, be it
Resolved by the House of Representatives (the Senate concur-
ring), That the Congress honors the life of Percy Lavon Julian, 
a pioneer in the field of organic chemistry research and development 
and the first and only African American chemist to be inducted 
into the National Academy of Sciences. 
Attest:
Clerk of the House of Representatives.
Attest:
Secretary of the Senate.
IV 
110TH CONGRESS 
1ST SESSION 
H. CON. RES. 34 
Honoring the life of Percy Lavon Julian, a pioneer in the field of organic 
chemistry research and development and the first and only African Amer-
ican chemist to be inducted into the National Academy of Sciences. 
IN THE HOUSE OF REPRESENTATIVES 
JANUARY 18, 2007 
Ms. EDDIE BERNICE JOHNSON of Texas (for herself, Mr. DAVIS of Illinois, 
Mr. RANGEL, Mr. GORDON of Tennessee, Mr. COSTELLO, Mr. ROHR-
ABACHER, Ms. NORTON, Mr. EHLERS, Ms. JACKSON-LEE of Texas, Ms. 
KILPATRICK of Michigan, Mr. HOLT, and Ms. MATSUI) submitted the fol-
lowing concurrent resolution; which was referred to the Committee on 
Science and Technology 
CONCURRENT RESOLUTION 
Honoring the life of Percy Lavon Julian, a pioneer in the 
field of organic chemistry research and development and 
the first and only African American chemist to be in-
ducted into the National Academy of Sciences. 
Whereas Percy Julian was born on April 11, 1899, in Mont-
gomery, Alabama, the son of a railway clerk and the first 
member of his family to attend college, graduating from 
DePauw University in 1920, receiving a M.S. degree 
from Harvard University in 1923 and a Ph.D. from the 
University of Vienna in 1931; 
VerDate Aug 31 2005 
05:45 Jan 19, 2007
Jkt 059200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6300
E:\BILLS\HC34.IH
HC34
bajohnson on PROD1PC71 with BILLS
•HCON 34 IH 
Whereas in 1935 Dr. Julian became the first to discover a 
process to synthesize physostigmine, the drug used in the 
treatment of glaucoma; 
Whereas Dr. Julian later pioneered a commercial process to 
synthesize cortisone from soy beans and yams, enabling 
the widespread use of cortisone as an affordable treat-
ment of arthritis; 
Whereas Dr. Julian was the first African American chemist 
elected to the National Academy of Sciences in 1973 for 
his lifetime of scientific accomplishments, held over 130 
patents at the time of his death in 1975, and dedicated 
much of his life to the advancement of African Americans 
in the sciences; and 
Whereas Dr. Julian’s life story has been documented in the 
PBS NOVA film ‘‘Forgotten Genius’’: Now, therefore, be 
it 
Resolved by the House of Representatives (the Senate 
concurring), That the Congress honors the life of Percy 
Lavon Julian, a pioneer in the field of organic chemistry 
research and development and the first and only African 
American chemist to be inducted into the National Acad-
emy of Sciences. 
Æ 
VerDate Aug 31 2005 
05:45 Jan 19, 2007
Jkt 059200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6301
E:\BILLS\HC34.IH
HC34
bajohnson on PROD1PC71 with BILLS
III 
110TH CONGRESS 
1ST SESSION 
H. CON. RES. 34 
IN THE SENATE OF THE UNITED STATES 
JANUARY 31, 2007 
Received 
CONCURRENT RESOLUTION 
Honoring the life of Percy Lavon Julian, a pioneer in the 
field of organic chemistry research and development and 
the first and only African American chemist to be in-
ducted into the National Academy of Sciences. 
Whereas Percy Julian was born on April 11, 1899, in Mont-
gomery, Alabama, the son of a railway clerk and the first 
member of his family to attend college, graduating from 
DePauw University in 1920, receiving a M.S. degree 
from Harvard University in 1923 and a Ph.D. from the 
University of Vienna in 1931; 
VerDate Aug 31 2005 
03:08 Feb 02, 2007
Jkt 059200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6300
E:\BILLS\HC34.RDS
HC34
mstockstill on PROD1PC62 with BILLS
HCON 34 RDS 
Whereas in 1935 Dr. Julian became the first to discover a 
process to synthesize physostigmine, the drug used in the 
treatment of glaucoma; 
Whereas Dr. Julian later pioneered a commercial process to 
synthesize cortisone from soy beans and yams, enabling 
the widespread use of cortisone as an affordable treat-
ment of arthritis; 
Whereas Dr. Julian was the first African American chemist 
elected to the National Academy of Sciences in 1973 for 
his lifetime of scientific accomplishments, held over 130 
patents at the time of his death in 1975, and dedicated 
much of his life to the advancement of African Americans 
in the sciences; and 
Whereas Dr. Julian’s life story has been documented in the 
PBS NOVA film ‘‘Forgotten Genius’’: Now, therefore, be 
it 
Resolved by the House of Representatives (the Senate 
concurring), That the Congress honors the life of Percy 
Lavon Julian, a pioneer in the field of organic chemistry 
research and development and the first and only African 
American chemist to be inducted into the National Acad-
emy of Sciences. 
Passed the House of Representatives January 31, 
2007. 
Attest: 
KAREN L. HAAS, 
Clerk. 
VerDate Aug 31 2005 
03:08 Feb 02, 2007
Jkt 059200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\HC34.RDS
HC34
mstockstill on PROD1PC62 with BILLS
the Office of Women’s Health (referred to in this section 
as the ‘Office’). The Office shall be headed by a director 
who shall be appointed by the Commissioner of Food and 
Drugs. 
‘‘(b) PURPOSE.—The Director of the Office shall— 
‘‘(1) report to the Commissioner of Food and 
Drugs on current Food and Drug Administration 
(referred to in this section as the ‘Administration’) 
levels of activity regarding women’s participation in 
clinical trials and the analysis of data by sex in the 
testing of drugs, medical devices, and biological 
products across, where appropriate, age, biological, 
and sociocultural contexts; 
‘‘(2) establish short-range and long-range goals 
and objectives within the Administration for issues 
of particular concern to women’s health within the 
jurisdiction of the Administration, including, where 
relevant and appropriate, adequate inclusion of 
women and analysis of data by sex in Administration 
protocols and policies; 
‘‘(3) provide information to women and health 
care providers on those areas in which differences 
between men and women exist; 
‘‘(4) consult with pharmaceutical, biologics, and 
device manufacturers, health professionals with ex-
VerDate Aug 31 2005 
01:34 Feb 21, 2007
Jkt 059200
PO 00000
Frm 00019
Fmt 6652
Sfmt 6201
E:\BILLS\H1072.IH
H1072
mstockstill on PROD1PC66 with BILLS
pertise in women’s issues, consumer organizations, 
and women’s health professionals on Administration 
policy with regard to women; 
‘‘(5) make annual estimates of funds needed to 
monitor clinical trials and analysis of data by sex in 
accordance with needs that are identified; and 
‘‘(6) serve as a member of the Department of 
Health and Human Services Coordinating Com-
mittee on Women’s Health (established under sec-
tion 229(b)(4) of the Public Health Service Act). 
‘‘(c) COORDINATING COMMITTEE.— 
‘‘(1) ESTABLISHMENT.—In carrying out sub-
section (b), the Director of the Office shall establish 
a committee to be known as the Coordinating Com-
mittee on Women’s Health (referred to in this sub-
section as the ‘Coordinating Committee’). 
‘‘(2) COMPOSITION.—The Coordinating Com-
mittee shall be composed of the directors of the cen-
ters of the Administration. 
‘‘(3) CHAIRPERSON.—The Director of the Of-
fice shall serve as the Chairperson of the Coordi-
nating Committee. 
‘‘(4) DUTIES.—With respect to women’s health, 
the Coordinating Committee shall assist the Director 
of the Office in— 
VerDate Aug 31 2005 
01:34 Feb 21, 2007
Jkt 059200
PO 00000
Frm 00020
Fmt 6652
Sfmt 6201
E:\BILLS\H1072.IH
H1072
mstockstill on PROD1PC66 with BILLS
‘‘(A) identifying whether there is a need 
for further studies and, if so, developing strate-
gies to foster such studies; 
‘‘(B) identifying issues in specific areas of 
women’s health that fall within the mission of 
the Administration; 
‘‘(C) identifying whether any need exists 
for the coordination of Administration activi-
ties, including internal and external activities; 
‘‘(D) maintaining the Administration’s 
focus in areas of importance to women; 
‘‘(E) supporting the development of meth-
odologies to determine how to obtain data spe-
cific to women (including data relating to the 
age of women and the membership of women in 
ethnic or racial groups); and 
‘‘(F) supporting the development and ex-
pansion of clinical trials of treatments and 
therapies for which obtaining such data has 
been determined to be an appropriate function. 
‘‘(d) REPORTS.—Not later than 1 year after the date 
of enactment of this section, and every second year there-
after, the Director of the Office shall prepare and submit 
to the appropriate committees of Congress a report de-
VerDate Aug 31 2005 
01:34 Feb 21, 2007
Jkt 059200
PO 00000
Frm 00021
Fmt 6652
Sfmt 6201
E:\BILLS\H1072.IH
H1072
mstockstill on PROD1PC66 with BILLS
scribing the activities carried out under this section during 
the period for which the report is being prepared. 
‘‘(e) AUTHORIZATION OF APPROPRIATIONS.—For the 
purpose of carrying out this section, there are authorized 
to be appropriated such sums as may be necessary for 
each of the fiscal years 2008 through 2012. 
‘‘(f) LIMITATION ON TERMINATION OF OFFICE.— 
Notwithstanding any other provision of law, the Office es-
tablished under this section may not be terminated, reor-
ganized, or have any of its powers or duties transferred 
unless such termination, reorganization, or transfer is ap-
proved by Congress through the adoption of a concurrent 
resolution of approval.’’. 
SEC. 9. NO NEW REGULATORY AUTHORITY. 
Nothing in this Act and the amendments made by 
this Act may be construed as establishing regulatory au-
thority or modifying any existing regulatory authority. 
SEC. 10. LIMITATION ON TERMINATION. 
Notwithstanding any other provision of law, a Fed-
eral office of women’s health (including the Office of Re-
search on Women’s Health of the National Institutes of 
Health) or Federal appointive position with primary re-
sponsibility over women’s health issues (including the As-
sociate Administrator for Women’s Services under the 
Substance Abuse and Mental Health Services Administra-
VerDate Aug 31 2005 
01:34 Feb 21, 2007
Jkt 059200
PO 00000
Frm 00022
Fmt 6652
Sfmt 6201
E:\BILLS\H1072.IH
H1072
mstockstill on PROD1PC66 with BILLS
tion) that is in existence on the date of enactment of this 
Act shall not be terminated, reorganized, or have any of 
its powers or duties transferred unless such termination, 
reorganization, or transfer is approved by Congress 
through the adoption of a concurrent resolution of ap-
proval. 
Æ 
VerDate Aug 31 2005 
01:34 Feb 21, 2007
Jkt 059200
PO 00000
Frm 00023
Fmt 6652
Sfmt 6301
E:\BILLS\H1072.IH
H1072
mstockstill on PROD1PC66 with BILLS
133 
‘‘(2) ADMINISTRATIVE
SUPPORT.—The Sec-
retary shall furnish the Advisory Committee clerical 
and other assistance. 
‘‘(3) NONAPPLICATION OF FACA.—Section 14 of 
the Federal Advisory Committee Act does not apply 
to the Advisory Committee. 
‘‘(e) PROCEEDINGS OF ADVISORY PANELS AND COM-
MITTEES.—The Advisory Committee shall make and 
maintain a transcript of any proceeding of the panel or 
committee. Each such panel and committee shall delete 
from any transcript made under this subsection informa-
tion which is exempt from disclosure under section 552(b) 
of title 5, United States Code. 
‘‘SEC. 918. DRUG PRODUCTS USED TO TREAT TOBACCO DE-
PENDENCE. 
‘‘(a) IN GENERAL.—The Secretary shall— 
‘‘(1) at the request of the applicant, consider 
designating products for smoking cessation, includ-
ing nicotine replacement products as fast track re-
search and approval products within the meaning of 
section 506; 
‘‘(2) consider approving the extended use of nic-
otine replacement products (such as nicotine patch-
es, nicotine gum, and nicotine lozenges) for the 
treatment of tobacco dependence; and
I 
110TH CONGRESS 
1ST SESSION H. R. 1073 
To amend the definition of a law enforcement officer under subchapter III 
of chapter 83 and chapter 84 of title 5, United States Code, respectively, 
to ensure the inclusion of certain positions. 
IN THE HOUSE OF REPRESENTATIVES 
FEBRUARY 15, 2007 
Mr. FILNER (for himself and Mr. MCHUGH) introduced the following bill; 
which was referred to the Committee on Oversight and Government Reform 
A BILL 
To amend the definition of a law enforcement officer under 
subchapter III of chapter 83 and chapter 84 of title 
5, United States Code, respectively, to ensure the inclu-
sion of certain positions. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Law Enforcement Offi-
cers Equity Act’’. 
SEC. 2. AMENDMENTS. 
(a) FEDERAL EMPLOYEES’ RETIREMENT SYSTEM.— 
VerDate Aug 31 2005 
01:42 Feb 21, 2007
Jkt 059200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H1073.IH
H1073
mstockstill on PROD1PC66 with BILLS
(1) IN GENERAL.—Paragraph (17) of section 
8401 of title 5, United States Code, is amended by 
striking ‘‘and’’ at the end of subparagraph (C), and 
by adding at the end the following: 
‘‘(E) an employee (not otherwise covered 
by this paragraph)— 
‘‘(i) the duties of whose position in-
clude the investigation or apprehension of 
individuals suspected or convicted of of-
fenses against the criminal laws of the 
United States; and 
‘‘(ii) who is authorized to carry a fire-
arm; and 
‘‘(F) an employee of the Internal Revenue 
Service, the duties of whose position are pri-
marily the collection of delinquent taxes and the 
securing of delinquent returns;’’. 
(2) 
CONFORMING
AMENDMENT.—Section 
8401(17)(C) of title 5, United States Code, is 
amended by striking ‘‘subparagraph (A) and (B)’’ 
and inserting ‘‘subparagraphs (A), (B), (E), and 
(F)’’. 
(b) CIVIL SERVICE RETIREMENT SYSTEM.—Para-
graph (20) of section 8331 of title 5, United States Code, 
is amended by inserting after ‘‘position.’’ (in the matter 
VerDate Aug 31 2005 
01:42 Feb 21, 2007
Jkt 059200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H1073.IH
H1073
mstockstill on PROD1PC66 with BILLS
before subparagraph (A)) the following: ‘‘For the purpose 
of this paragraph, the employees described in the pre-
ceding provision of this paragraph (in the matter before 
‘including’) shall be considered to include an employee, not 
otherwise covered by this paragraph, who satisfies clauses 
(i)–(ii) of section 8401(17)(E) and an employee of the In-
ternal Revenue Service the duties of whose position are 
as described in section 8401(17)(F).’’. 
(c) EFFECTIVE DATE.—Except as provided in section 
3, the amendments made by this section shall take effect 
on the date of the enactment of this Act, and shall apply 
only in the case of any individual first appointed as a law 
enforcement officer (within the meaning of those amend-
ments) on or after such date. 
SEC. 3. TREATMENT OF SERVICE PERFORMED BY INCUM-
BENTS. 
(a) LAW ENFORCEMENT OFFICER AND SERVICE DE-
SCRIBED.— 
(1) LAW
ENFORCEMENT
OFFICER.—Any ref-
erence to a law enforcement officer described in this 
subsection refers to an individual who satisfies the 
requirements of section 8331(20) or 8401(17) of 
title 5, United States Code (relating to the definition 
of a law enforcement officer) by virtue of the amend-
ments made by section 2. 
VerDate Aug 31 2005 
01:42 Feb 21, 2007
Jkt 059200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H1073.IH
H1073
mstockstill on PROD1PC66 with BILLS
110TH CONGRESS 
2D SESSION 
H. CON. RES. 351 
CONCURRENT RESOLUTION 
Whereas, in response to the financial difficulties of the times, 
the Continental Congress departed the city of Philadel-
phia suddenly due to a possible uprising by discontented 
Continental Army soldiers who had not been paid; 
Whereas the President of the Continental Congress, Elias 
Boudinot, 
established 
a 
temporary 
capital 
at
•HCON 351 EH 
Princeton ‘‘in order that further and more effective meas-
ures may be taken for suppressing the present Revolt, 
and maintaining the Dignity and Authority of the United 
States’’; 
Whereas members of the Continental Congress were in-
structed to meet in Princeton on June 26, 1783; 
Whereas the 300 residents of Princeton took members of the 
Congress into their homes; 
Whereas Princeton University offered the prayer hall and the 
library in Nassau Hall for Congress to use to conduct the 
governmental business of the United States; 
Whereas the Congress conducted essential business in Nassau 
Hall, which helped shape the foreign relations of the 
fledgling Nation; 
Whereas General George Washington was called to Princeton 
by a letter from President Boudinot to receive the formal 
thanks of the Nation for his dedicated service as com-
mander-in-chief; 
Whereas, on August 18, General Washington left Major Gen-
eral John Knox in charge of the encamped army at New-
burgh, New York, and traveled with a guard of dragoons 
and his wife, Martha Washington, to the Rockingham es-
tate in Rocky Hill, New Jersey, which was made available 
for his use over the next three months; 
Whereas General Washington met with the Continental Con-
gress in Nassau Hall on August 26 and received the pub-
lic thanks of his country for his success in the struggle 
for liberty; 
Whereas, in late October at Rockingham, Washington com-
pleted writing his Farewell Orders to the Armies of the
•HCON 351 EH 
United States dismissing the troops and announcing his 
retirement; 
Whereas, while Congress was meeting in Princeton, the Trea-
ty of Paris was signed in Paris by John Adams, John 
Jay, and Benjamin Franklin on September 3, 1783, 
marking the end of the American Revolution and estab-
lishing the boundaries of the new Nation; and 
Whereas Congress departed Princeton in early November 
1783 to winter in Annapolis, Maryland: Now, therefore, 
be it 
Resolved by the House of Representatives (the Senate 
concurring), That it is the sense of the Congress that the 
225th Anniversary of the Continental Congress meeting 
at Nassau Hall in Princeton, New Jersey, should be com-
memorated. 
Passed the House of Representatives September 24 
(legislative day September 23), 2008. 
Attest: 
Clerk.
110TH CONGRESS 
2D SESSION 
H. CON. RES. 351 
CONCURRENT RESOLUTION 
Honoring the 225th Anniversary of the Continental 
Congress meeting in Nassau Hall, Princeton, 
New Jersey, in 1783.
(2) SERVICE.—Any reference to service de-
scribed in this subsection refers to service performed 
as a law enforcement officer (as described in this 
subsection). 
(b) INCUMBENT DEFINED.—For purposes of this sec-
tion, the term ‘‘incumbent’’ means an individual who— 
(1) is first appointed as a law enforcement offi-
cer (as described in subsection (a)) before the date 
of the enactment of this Act; and 
(2) is serving as such a law enforcement officer 
on such date. 
(c) TREATMENT OF SERVICE PERFORMED BY INCUM-
BENTS.— 
(1) IN
GENERAL.—Service described in sub-
section (a) which is performed by an incumbent on 
or after the date of the enactment of this Act shall, 
for all purposes (other than those to which para-
graph (2) pertains), be treated as service performed 
as a law enforcement officer (within the meaning of 
section 8331(20) or 8401(17) of title 5, United 
States Code, as appropriate). 
(2) RETIREMENT.—Service described in sub-
section (a) which is performed by an incumbent be-
fore, on, or after the date of the enactment of this 
Act shall, for purposes of subchapter III of chapter 
VerDate Aug 31 2005 
01:42 Feb 21, 2007
Jkt 059200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H1073.IH
H1073
mstockstill on PROD1PC66 with BILLS